Opinion: RN Experience Should Precede NP Training
A MedPage Today opinion piece argues that nurse practitioner education should require prior registered nurse work experience to protect the profession's integrity.
An opinion piece published by MedPage Today makes the case that aspiring nurse practitioners (NPs) should first work as registered nurses (RNs) before entering NP school. The author, who explicitly states they are not anti-NP, expresses concern that the profession has drifted from its roots by allowing students to advance without substantial bedside experience.
The argument centers on the idea that advanced practice requires a solid foundation in direct patient care. The author believes that RN experience provides essential clinical judgment, hands-on skills, and a deeper understanding of patient needs—qualities that cannot be fully taught in a classroom. Without this prerequisite, the piece warns, NPs may enter practice less prepared, which could ultimately harm patients and the profession's reputation.
The article does not present data or opposing views; it is a personal opinion. However, it raises a timely question about NP education standards, especially as the role of NPs expands in healthcare. The author's stance is clear: protect the profession by ensuring that NP candidates have proven themselves as RNs first.
More in Medicine & Biotech
Ebola Vaccine Trial Launches in DR Congo Outbreak Zone
Health workers in DR Congo have begun testing whether a vaccine designed for a different Ebola strain can protect against the current outbreak.
Beacon Gene Therapy for Rare Vision Loss Succeeds in Pivotal Trial
A pivotal trial of Beacon Therapeutics' gene therapy for X-linked retinitis pigmentosa improved visual acuity, clearing the path toward an FDA submission.
Alkermes orexin agonist shows early promise for ADHD
Early-stage data suggest Alkermes' orexin agonist could expand the drug class beyond sleep disorders into ADHD.
Telix to Buy ITM for $1.65B, Challenging Novartis in Radiopharma
The acquisition gives Telix a late-stage pipeline and supply network that could compete with Novartis' Lutathera.